Share on:
Shanghai Sanyou Medical received a $14.0MM investment from Chinese investment firm Yingke Private Equity. Sanyou plans to use the funds to invest in research and development, as well as accelerate its initial public offering process.
Founded in 2005, the orthopaedic device developer holds 21 patents and 48 utility models in China. Products include “Z” Minimally Invasive Spine Technology that purportedly reduces surgery time by 50% and surgical incision size by 30%. The company’s Tytus Labs offers R&D assistance from prototyping to mechanical and biomechanical analysis.
As a startup, the company raised Series A funds with investments from Qiming Venture Partners and TF Capital in 2014.
Sources: Shanghai Sanyou Medical
RELATED ARTICLES
Norwood Medical Appoints Gregg Olson as VP Sales & Marketing
Mar 27 2024 , Julie A. Vetalice
Tapping into the Promising Potential of AI in Orthopedics
Mar 26 2024 , BONEZONE Editors
4 Benefits of Additive Manufacturing Design in the Orthopedic Market
Mar 25 2024 , Paragon Medical
Materials Solutions for Medical Device Instrumentation
Mar 22 2024 , Carpenter Technology